Showing results (191-200 of 240) with videos related to

Sort By:
Pageof 24
Endocrine Connections|November 5, 2017
Increased circulating interleukin-8 in patients with resistance to thyroid hormone receptor αAnne H van der Spek, Olga V Surovtseva, Saskia Aan, et al.
European Journal of Immunology|September 28, 2017
Genetic variation of human neutrophil Fcγ receptors and SIRPα in antibody-dependent cellular cytotoxicity towards cancer cellsLouise W Treffers, Xi Wen Zhao, Joris van der Heijden, et al.
Cancer Immunology Research|December 23, 2020
Kindlin3-Dependent CD11b/CD18-Integrin Activation Is Required for Potentiation of Neutrophil Cytotoxicity by CD47-SIRPα Checkpoint DisruptionPanagiota Bouti, Xi Wen Zhao, Paul J J H Verkuijlen, et al.
Blood|January 11, 2013
A novel flow cytometry-based platelet aggregation assayIris M De Cuyper, Marjolein Meinders, Edith van de Vijver, et al.
Blood|January 22, 2013
Invasive fungal infection and impaired neutrophil killing in human CARD9 deficiencyAgata Drewniak, Roel P Gazendam, Anton T J Tool, et al.
Blood Advances|January 4, 2018
The class I scavenger receptor CD163 promotes internalization of ADAMTS13 by macrophagesFabian C Verbij, Nicoletta Sorvillo, Paul H P Kaijen, et al.
European Heart Journal|May 15, 2007
Variations in the use of emergency PCI for the treatment of re-infarction following intravenous fibrinolytic therapy: impact on outcomes in HERO-2J J Edmond, J K French, P E G Aylward, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 2, 2011
CD47-signal regulatory protein-α (SIRPα) interactions form a barrier for antibody-mediated tumor cell destructionXi Wen Zhao, Ellen M van Beek, Karin Schornagel, et al.
Frontiers in Immunology|February 12, 2021
Myeloid Ezh2 Deficiency Limits Atherosclerosis DevelopmentAnnette E Neele, Hung-Jen Chen, Marion J J Gijbels, et al.
Blood|December 10, 2008
LAD-1/variant syndrome is caused by mutations in FERMT3Taco W Kuijpers, Edith van de Vijver, Marian A J Weterman, et al.
Pageof 24